Wainman Paul R

Avg. Two Year Performance

(2%) Avg. Purchase Return
(1%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)10%13%8%(2%)
Purchase Success Rate3 of 54 of 53 of 54 of 53 of 5
Average Sale Return----------
Sale Success Rate----------

ImmuCell Corp.

Drugs » Diagnostic Substances

Director:

Holdings: 6.27K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--